Related Experiment Video
Updated: Aug 12, 2026

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
The epidemiology of parainfluenza virus infection in lung transplant recipients
R A Vilchez1, K McCurry, J Dauber
1Department of Medicine, University of Pittsburgh Medical Center, and Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, USA.
Abstract:
Human parainfluenza virus (HPIV) is a common cause of seasonal respiratory tract infections. However, little is known about the clinical presentation and impact of HPIV infections in lung transplant recipients. We reviewed HPIV infections at the University of Pittsburgh Medical Center. From January 1990 through May 2000, 32 cases of HPIV infection were identified. HPIV infection was found in 24 lung transplant recipients (75%), all of whom were included in the study group. Diagnosis was established at a median of 2.1 years after transplantation (range, 0.6-5 years). Presenting symptoms included cough (17 patients), shortness of breath (16), and temperature elevation (4). Respiratory failure occurred in 5 patients (21%). The HPIV serotypes were HPIV-1 (7 patients), HPIV-2 (2), and HPIV-3 (15 [63%]). Twenty-two patients underwent transbronchial biopsy, and 18 (82%) showed signs of acute allograft rejection. Seven patients (32%) subsequently were found to have bronchiolitis obliterans.
Insights
Human parainfluenza virus (HPIV) infections are common in lung transplant recipients, often presenting with respiratory symptoms. A significant portion of these patients experienced acute allograft rejection and bronchiolitis obliterans.
Area of Science:
- Virology
- Transplantation Immunology
- Pulmonary Medicine
Background:
- Human parainfluenza virus (HPIV) causes seasonal respiratory infections.
- The clinical impact of HPIV in lung transplant recipients remains poorly understood.
Purpose of the Study:
- To investigate the clinical presentation and outcomes of HPIV infections in lung transplant recipients.
Main Methods:
- Retrospective review of HPIV infections at a single center from 1990-2000.
- Analysis of patient demographics, clinical symptoms, HPIV serotypes, and post-infection complications.
Main Results:
- HPIV infection was identified in 24 (75%) of 32 cases reviewed, occurring a median of 2.1 years post-transplant.
- Common symptoms included cough and shortness of breath; 21% experienced respiratory failure.
- HPIV-3 was the most prevalent serotype (63%).
- 82% of patients with biopsies showed acute allograft rejection, and 32% developed bronchiolitis obliterans.
Conclusions:
- HPIV infection poses a significant risk for lung transplant recipients.
- HPIV infection is associated with a high incidence of acute allograft rejection and bronchiolitis obliterans in this population.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Influenza
Pneumonia I: Introduction

